Guest post by Lawrence Sellin and Anna Chen
The Chinese People’s Liberation Army believes that biological weapons, not nuclear weapons, are the key to global military dominance.
In our recent Gateway Pundit article, we reviewed the 2005 and 2006 Chinese military publications by Colonel Ji-wei Guo, who advocated the use of biotechnology in developing new methods of warfare and recommended that military physicians be involved in the making bioweapons.
In his 2008 book, “Biological Outlook on War and Foresight of Biotechnology Supremacy,” Colonel Guo elaborated on the application of biotechnology in bio-based wars, representing the “Third Leap” in military strategy:
“The third leap includes biotechnology and related sciences that develop and grow based on information technology (including advanced computing and communications), nanoscience and other convergence technologies, merging biotechnology and biomedical science (including genetic engineering), cognitive science (including cognitive neuroscience). extensively applied. It will cause enormous quantitative changes in the combat environment, combat methods, space-time relations, military structure and function, and will eventually lead to new qualitative changes, which will profoundly change modern military history. The change at the operational level that this military transformation brings is the further expansion of the theory of power control with modern biotechnology as its main feature.
TRENDING: BRAVO! GOP Representatives Jordan, Johnson, Steube, Biggs, Gohmert, Spartz, Massie, Gaetz, Chabot, McClintock and Ken Buck DESTROY AG Garland at Hearing (VIDEO)
Colonel Guo’s comments not only represented the arbitrary musings of a particular Chinese military officer, but were concepts embraced by the Chinese People’s Liberation Army and embedded in its military doctrine.
In his 2012 article “Military Biotechnology Development and the Future of Bio-Based War,” Major General Fu-Chu He wrote:
“As an emerging technology, military biotechnology expands the concept of weapons and equipment and becomes a major driver of weapons and equipment development. In recent years, major breakthroughs have been made in many fields of military biotechnology, such as synthetic biology, brain-computer interface and brain control, biological materials, bio-inspired machines, biofuels, bioelectronics, bio-computing and non-lethal weapons. , leading to the birth of new operational concepts. In future wars, military biotechnology will promote bio-based weapons and equipment, bio-based armed forces and bio-based combat style.”
Major General Fu-Chu He was chairman of the Academy of Military Medical Sciences, vice chairman of the Chinese Academy of Medical Sciences, an alternate member of the 18th Central Committee of the Chinese Communist Party and vice director of the Scientific and Technical Committee attached to the Central Army Commission, the Chinese equivalent of the US Department of Defense’s DARPA, the Defense Advanced Research Projects Agency.
Major General Chen Wei is currently the director of the Institute of Biotechnology, Academy of Military Medical Sciences and presumed head of China’s biological warfare program.
She was given command of the ‘cleanup operation’ in Wuhan after local authorities lost control of the COVID-19 outbreak. She also led China’s efforts to create a COVID-19 vaccine.
Major General Chen Wei, published in 2014, co-authored the book “Biotechnology Development Yearbook, 2013”, which describes key biotechnology advances and their impact on military medical science.
The book contains 10 sections covering 25 specific biotechnology topics, including gene engineering, synthetic biology, gene sequencing, biotherapeutics, biomaterials, bioinformatics, bioimaging, cloning and neurobiology.
In 2016, the Science and Technology Military-Civil Fusion Program of the Thirteenth Five Year Plan was launched by the Scientific and Technical Committee affiliated to the Central Military Commission.
That program included all Chinese universities, pharmaceutical companies, and “civil” research centers, such as the Wuhan Institute of Virology, into the People’s Liberation Army’s biotech warfare.
Unsurprisingly, then, Major General Chen Wei’s predecessor as Director of the Institute of Biotechnology and retired Vice President of the Academy of Military Medical Sciences, Major General Pei-Tang Huang became an independent director of Hualan Biological on April 26. bacteria inc. 2019.
Given the intensity of the military-civilian research fusion program, it may not be a coincidence that in the two to three months following Pei-Tang Huang’s appointment, the directors of twenty-three multinational and domestic pharmaceutical companies across China resigned or retired, including Sanofi, Roche, Bayer, Bristol-Myers Squibb and General Electric Healthcare.
In April 2021, Hualan Biological Bacterin Inc. entered into an exclusive agreement with the Russian government to produce 100 million doses of the Sputnik V COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Ministry of Health.
None of the above seems to have caught the attention of those responsible for US national security.
Clearly, the US Department of Defense and US intelligence agencies lack a basic understanding of the direction and scope of China’s biotech warfare program.
US government officials seem unaware that COVID-19 was certainly part of that program, perhaps even a test of it.
Lawrence Sellin, Ph.D. is a retired colonel from the United States Army Reserve and a veteran of Afghanistan and Iraq. He had a civilian career in international business and medical research. His email address is [email protected]. Anna Chen can be followed on Twitter @2020Gladiator